Maruti Suzuki India Limited has reported strong production growth for February 2026, with total vehicle production reaching 223,507 units compared to 187,414 units in February 2025. The automotive manufacturer disclosed these figures in a regulatory filing under Regulation 30, signed by Executive Officer & Company Secretary Sanjeev Grover on March 1, 2026.

Overall Production Performance

The company's total production witnessed a robust 19.3% year-on-year growth, driven primarily by significant expansion in the utility vehicles segment. The production data encompasses both passenger vehicles and light commercial vehicles across various model categories.

Segment-wise Production Analysis

Passenger Cars Performance

The passenger cars segment, comprising mini and compact sub-segments, produced 103,867 units in February 2026 compared to 104,947 units in February 2025. The mini segment, including Alto and S-Presso models, showed strong growth with 15,783 units against 12,198 units in the previous year.

Utility Vehicles Drive Growth

The utility vehicles segment emerged as the primary growth driver, recording exceptional performance with 102,834 units produced in February 2026 against 66,647 units in February 2025. This segment includes popular models such as Brezza, Ertiga, e Vitara, Fronx, Jimny, Victoris, and XL6, along with OEM models.

Commercial Vehicles and Vans

The vans category, represented by the Eeco model, maintained steady production levels with 12,911 units in February 2026 compared to 12,405 units in the previous year. Light commercial vehicles, specifically the Super Carry model, contributed 3,895 units to the overall production volume.

Regulatory Compliance

The production figures were submitted to both the National Stock Exchange of India Limited and BSE Limited as part of the company's regulatory obligations. The disclosure was made through a formal communication from the company's registered office in New Delhi, ensuring transparency in operational performance reporting.

Maruti Suzuki India Limited has notified stock exchanges about the adjournment of its National Company Law Appellate Tribunal (NCLAT) hearing from 27th February 2026 to 25th March 2026, following partial completion of arguments during the scheduled hearing.

Case Background and Timeline

The legal proceedings stem from a Competition Commission of India (CCI) order dated 23rd August 2021 against the company. NCLAT granted an interim stay on this CCI order on 22nd November 2021, providing temporary relief to Maruti Suzuki while the appeal process continues.

Recent Hearing Developments

The company's disclosure reveals that arguments in the matter were partially heard during the 27th February 2026 hearing. The tribunal has now scheduled the next hearing for 25th March 2026 to continue with further arguments from both parties.

Extended Legal Process

This case has experienced numerous adjournments since the initial hearing was scheduled for 9th September 2022. The matter has been rescheduled multiple times across 2022, 2023, 2024, 2025, and now into 2026, reflecting the complex nature of the proceedings.

Key phases in the legal timeline include:

• Initial Phase (2022): Written submissions filed and first hearing scheduled
• Multiple Adjournments (2022-2023): Several rescheduling due to various procedural reasons
• Arguments Phase (2024-2026): Commencement of oral arguments with ongoing adjournments

Regulatory Compliance

Maruti Suzuki has maintained consistent disclosure practices under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, keeping stakeholders informed about each hearing date and adjournment throughout the extended legal process.

The company continues to operate under the protection of the interim stay granted by NCLAT in November 2021, which remains effective pending the final resolution of the appeal against the CCI order.